Skip to main content

Risk-standardized Complication Rate (RSCR) following Elective Primary Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA) for Eligible Clinicians and Eligible Clinician Groups

CBE ID
3493
Endorsement Status
1.0 New or Maintenance
1.1 Measure Structure
Previous Endorsement Cycle
Is Under Review
Yes
Next Maintenance Cycle
Spring 2025
1.6 Measure Description

The primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA) complication measure assesses risk-standardized complication rates (RSCRs) for individual clinicians or groups of clinicians to improve the quality of care delivered to their patients.  

This re-specified measure includes THA/TKA procedures performed in both inpatient and outpatient (hospital outpatient department and Ambulatory Surgery Centers [ASC]) settings among eligible Medicare Fee-For-Service (FFS) beneficiaries who are at least 65 years of age. 

The measure captures specific coded complications that occur at the index admission/encounter or during a readmission, observation stay, emergency department (ED) visit, or ASC encounter. 

Measure Specs
General Information
1.7 Measure Type
1.3 Electronic Clinical Quality Measure (eCQM)
1.10 Measure Rationale

The goal of the Risk-standardized Complication Rate (RSCR) following Elective Primary Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA) for Eligible Clinicians and Eligible Clinician Groups  measure (hereafter referred to as THA/TKA Complications measure for ECs and EC Groups) is to improve patient outcomes by providing patients, physicians, hospitals, and policymakers with information about RSCR following primary elective THA and/or TKA. More specifically, the measure aims to improve patient outcomes by providing more information about serious complications that require facility-based care following primary elective THA and TKA. 

The list of serious complications included in the measure was adopted based on those complications identified from the medical literature and in consultation with a working group and technical expert panel during the development of the Hospital-level Risk-standardized Complication rate (RSCR) following Elective Primary Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA) (CBE#1550) (hereafter referred to as Hospital-level THA/TKA Complications measure). Measurement of patient outcomes allows for a broad view of the quality of care that encompasses more than what can be captured by individual process-of-care measures. Complex and critical aspects of care, such as prevention of and response to complications, communication between clinicians, patient safety, and coordinated transitions to the outpatient environment, all contribute to patient outcomes but are difficult to measure using individual process measures. While most clinician-level quality improvement measures for patients undergoing elective THA and TKA procedures are generally focused on evidence-based processes of care, this measure informs quality improvement efforts targeted toward minimizing medical and surgical complications during surgery and the postoperative period for patients who have undergone THA and/or TKA.

This measure identifies Eligible Clinicians (ECs) or EC Groups responsible for the patients’ care and evaluates whether their performance is better or worse than would be expected based on each clinician’s patient case mix and therefore promotes clinician-level quality improvement. 

THA and/or TKA complications are a priority area for outcome measure development. It is an outcome that is reasonably attributable to surgeons who perform the procedure and is an important outcome for patients. Measuring and reporting rates of serious complications after THA/TKA procedures performed by ECs or EC Groups informs healthcare clinicians and facilities about opportunities to improve care, strengthens incentives for quality improvement and ultimately improves the quality of care received and outcomes experienced by Medicare patients. 

THA and TKA are commonly performed and costly procedures. According to the CMS Medicare/Medicaid Part B National Summary, in 2019 the annual volume of primary TKA was 480,958 and that of primary THA was 262,369 with forecasts suggesting an increase in demand for procedures due to gains in post-surgery care, the aging population, and increasing rates of osteoarthritis (Shichman et al., 2023). Complications following a THA/TKA can vary in frequency and drive the overall cost of these procedures, leading to a substantial burden on both the patient and the healthcare system (Schwarzkopf et al., 2019). Improving complex and critical aspects of care, such as communication between clinicians, rapid response to complications, patient safety, and coordinated transitions to the outpatient environment, all contribute to better patient outcomes (Ozdag et al., 2024; Zheng et al., 2019; Antonelli et al., 2019; Elbuluk et al, 2019). Complications increase costs associated with THA and TKA procedures and affect the quality of life for patients (Bumpass et al., 2012; Shearer et al., 2015). Although complications following elective primary THA and TKA are rare, the results can be devastating (Kurtz et al., 2012; Helwig et al,. 2014; Elsiwy et al., 2019). 

CMS implemented this measure in the Merit-based Incentive Payment System (MIPS) in 2021 because preventing complications of care following THA and TKA procedures reduces costs and promotes high-quality care and better patient outcomes. 

A series of changes announced in the Calendar Year (CY) 2018 and CY 2020-2021 Hospital Outpatient Prospective Payment System (OPPS) Final Rules removed TKA and THA procedures from the inpatient-only list, allowing both procedures to be performed in the outpatient setting (Centers for Medicare & Medicaid Services, 2018; 2019; 2020). Subsequently, in CY 2020 CMS added TKA procedures and in CY 2021 THA procedures to the Ambulatory Surgery Center (ASC) covered procedure list, making both procedures billable in the ASC setting as well (Centers for Medicare & Medicaid Services, 2018; 2019). These changes resulted in a sizable increase in the number of THA/TKAs performed in the outpatient setting, providing a rationale for the expansion of the current THA/TKA complication measure for ECs and EC Groups (Suter et al., 2020).

The re-specification of this previously endorsed measure includes expanding the measure cohort and outcome definition to include the increasing number of procedures performed in hospital outpatient and ASC settings (Xu et al., 2019; Aynardi et al., 2014; Arshi et al., 2019; Bert et al., 2017; Goyal et al., 2017; Darrith et al., 2019; Migliorini et al., 2021; Mariorenzi et al., 2020). 

References

Antonelli, B., & Chen, A. F. (2019). Reducing the risk of infection after total joint arthroplasty: preoperative optimization. Arthroplasty, 1(1). https://doi.org/10.1186/s42836-019-0003-7

Arshi, A., et al., Outpatient total hip arthroplasty in the United States: A population-based comparative analysis of complication rates. J Am Acad Orthop Surg, 2019. 27(2): p. 61-67. 

Aynardi, M., et al., Outpatient surgery as a means of cost reduction in total hip arthroplasty: A case-control study. HSS J, 2014. 10(3): p. 252-5.s 

Bert, J.M., J. Hooper, and S. Moen, Outpatient Total Joint Arthroplasty. Curr Rev Musculoskelet Med, 2017. 10(4): p. 567-574. 

Bumpass, D. B., & Nunley, R. M. (2012). Assessing the value of a total joint replacement. Current Reviews in Musculoskeletal Medicine, 5(4), 274–282. https://doi.org/10.1007/s12178-012-9139-6

Centers for Medicare & Medicaid Services (CMS) HHS, Medicare Program: Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs. Final Rule With Comment Period. Federal Register, 2018. 83: p. 58818-59179. 

Centers for Medicare & Medicaid Services (CMS) HHS, Medicare Program: Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs. Final Rule With Comment Period. Federal Register, 2019. 84: p. 61142-61492. 

Centers for Medicare & Medicaid Services (CMS), H., Medicare Program: Changes to Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs. Proposed Rule. Federal Register, 2020. 85: p. 50074-50665. 

Darrith, B., et al., Inpatient Versus Outpatient Arthroplasty: A Single-Surgeon, Matched Cohort Analysis of 90-Day Complications. J Arthroplasty, 2019. 34(2): p. 221-227. 

Elbuluk, A. M., Novikov, D., Gotlin, M., Schwarzkopf, R., Iorio, R., & Vigdorchik, J. (2018). Control Strategies for infection prevention in total joint arthroplasty. Orthopedic Clinics of North America, 50(1), 1–11. https://doi.org/10.1016/j.ocl.2018.08.001

Elsiwy, Y., Jovanovic, I., Doma, K., Hazratwala, K., & Letson, H. (2019). Risk factors associated with cardiac complication after total joint arthroplasty of the hip and knee: a systematic review. Journal of Orthopaedic Surgery and Research, 14(1). https://doi.org/10.1186/s13018-018-1058-9

Goyal, N., et al., Otto Aufranc Award: A Multicenter, Randomized Study of Outpatient versus Inpatient Total Hip Arthroplasty. Clin Orthop Relat Res, 2017. 475(2): p. 364-372. 

Helwig, P., Morlock, J., Oberst, M., Hauschild, O., Hübner, J., Borde, J., Südkamp, N. P., & Konstantinidis, L. (2014). Periprosthetic joint infection—effect on quality of life. International Orthopaedics, 38(5), 1077–1081. https://doi.org/10.1007/s00264-013-2265-y

Kurtz, S. M., Lau, E., Watson, H., Schmier, J. K., & Parvizi, J. (2012). Economic burden of periprosthetic joint infection in the United States. The Journal of Arthroplasty, 27(8), 61-65.e1. https://doi.org/10.1016/j.arth.2012.02.022

Mariorenzi, M., et al., Outpatient Total Joint Arthroplasty: A Review of the Current Stance and Future Direction. R I Med J (2013), 2020. 103(3): p. 63-67.

Migliorini F, C.L., Cuozzo F, Oliva F, Valerio Marino A, Maffulli N, Outpatient Total Hip Arthroplasty: A Meta-Analysis. Applied Sciences, 2021. 11(15): p. 6853-6864. 

Ozdag, Y., Makar, G. S., & Kolessar, D. J. (2024). Postoperative communication volume following total joint arthroplasty can be a precursor for emergency department visits. Arthroplasty Today, 27, 101352. https://doi.org/10.1016/j.artd.2024.101352

Schwarzkopf, R., Behery, O. A., Yu, H., Suter, L. G., Li, L., & Horwitz, L. I. (2019). Patterns and costs of 90-Day readmission for surgical and medical complications following total hip and knee arthroplasty. The Journal of Arthroplasty, 34(10), 2304–2307. https://doi.org/10.1016/j.arth.2019.05.046 

Schwarzkopf, R., Behery, O. A., Yu, H., Suter, L. G., Li, L., & Horwitz, L. I. (2019). Patterns and costs of 90-Day readmission for surgical and medical complications following total hip and knee arthroplasty. The Journal of Arthroplasty, 34(10), 2304–2307. https://doi.org/10.1016/j.arth.2019.05.046 

Shearer, D. W., Youm, J., & Bozic, K. J. (2015). Short-term Complications Have More Effect on Cost-effectiveness of THA than Implant Longevity. Clinical Orthopaedics and Related Research, 473(5), 1702–1708. https://doi.org/10.1007/s11999-014-4110-z

Shichman I, Roof M, Askew N, Nherera L, Rozell JC, Seyler TM, Schwarzkopf R. Projections and Epidemiology of Primary Hip and Knee Arthroplasty in Medicare Patients to 2040-2060. JB JS Open Access. 2023 Feb 28;8(1):e22.00112. doi: 10.2106/JBJS.OA.22.00112. PMID: 36864906; PMCID: PMC9974080.

Suter, L.G., et al., 90-Day Risk-Standardized Complication Rates Following Elective Total Hip Arthroplasty (THA) and/or Total Knee Arthroplasty (TKA) for a Potential Combined Inpatient and Outpatient Episode Payment Model (EPM) Business Case. 2020.sXu, J., et al., Comparison of outpatient versus inpatient total hip and knee arthroplasty: A systematic review and meta-analysis of complications. Journal of Orthopaedics, 2019. 17: p. 38-43. 

Zheng, Q., Geng, L., Ni, M., Sun, J., Ren, P., Ji, Q., Li, J., & Zhang, G. (2019). Modern instant messaging platform for postoperative follow-up of patients after total joint arthroplasty may reduce re-admission rate. Journal of Orthopaedic Surgery and Research, 14(1). https://doi.org/10.1186/s13018-019-1407-3

1.20 Types of Data Sources
1.25 Data Source Details

The measure uses administrative claims and enrollment data for measure reporting. For testing, we used Medicare administrative claims data and enrollment information for patients with qualifying procedures between April 1, 2019, and March 31, 2022, and extending through June 30, 2022, for the capture of complications. Specifically, we used the following data sources:

  1. Medicare inpatient, outpatient, and physician/professional claims: these include data for Medicare FFS inpatient and outpatient services such as Medicare inpatient hospital care, outpatient services, and physician claims for the 12 months prior to an index encounter and for the three months after. The professional claims are also used to identify the attributed clinician.
  2. Medicare Enrollment Database (EDB): This database contains Medicare beneficiary demographics, benefit/coverage, and vital status information. This data source is used to obtain information on several inclusion/exclusion indicators such as Medicare status on procedure, vital status at discharge, and death information post-discharge. This data has previously been shown to accurately reflect patient vital status.